Page last updated: 2024-08-24

triazoles and Depression, Involutional

triazoles has been researched along with Depression, Involutional in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.92)	18.2507
2000's	36 (70.59)	29.6817
2010's	8 (15.69)	24.3611
2020's	5 (9.80)	2.80

Authors

Authors	Studies
Jha, MK	1
Alves, D; Fronza, MG; Praticò, D; Sacramento, M; Savegnago, L	1
de Boer, P; Drevets, W; Jacobs, G; Kent, J; Luthringer, R; Recourt, K; van der Ark, P; van Gerven, J; Van Hove, I; van Nueten, L; Zuiker, R	1
de Boer, P; de Kam, M; Drevets, W; Jacobs, G; Kanhai, K; Ravenstijn, P; Recourt, K; Siebenga, P; Timmers, M; van der Aart, J; van Gerven, J; van Nueten, L; Zuiker, R	1
Canuso, C; Davidson, M; Davis, JM; Ford, L; Levi, L; Nastas, I; Park, J; Rassnick, S; Weiser, M	1
Drevets, WC; Etropolski, M; Savitz, A; Thase, ME; Wajs, E; Xu, H; Zhang, Y	1
Furmaga, K; Petrous, J	1
Brooks, S; de Boer, P; Drevets, W; Jacobs, GE; Kent, JM; Kezic, I; Luthringer, R; van Amerongen, G; van der Ark, P; van Gerven, JM; Van Nueten, L; Zuiker, R	1
Arnow, BA; Blasey, C; Klein, DN; Kocsis, JH; Manber, R; Markowitz, JC; Rothbaum, BO; Steidtmann, D; Thase, ME	1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X	1
Preskorn, SH	1
Arnow, BA; Gelenberg, AJ; Keller, ME; Klein, DN; Kocsis, JH; Kraemer, HC; Manber, R; Rothbaum, BO; Rush, AJ; Thase, ME; Trivedi, MH	1
Arnow, B; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Markowitz, JC; Thase, ME	1
Arnow, BA; Blalock, JA; Keitner, GI; Klein, DN; Maddux, RE; Manber, R; Markowitz, JC; Riso, LP; Rothbaum, BO; Thase, ME	1
Arnow, BA; Carmody, TJ; Denton, WH; Keller, MB; Klein, DN; Rush, AJ; Thase, ME; Trivedi, MH	1
Crits-Christoph, P; Klein, DN; Manber, R; Stulz, N; Thase, ME	1
Blom, MB; Hoek, HW; Hoencamp, E; Judith Haffmans, PM; Spinhoven, P; van Dyck, R	1
Beckham, JC; Davidson, JR; Feldman, ME; Hertzberg, MA; Moore, SD	1
Amow, B; Borian, FE; Dunner, DL; Keller, B; Klein, D; Korenstein, SG; Manber, R; Markowitz, JC; Munsaka, M; Rush, AJ; Thase, ME; Trivedi, MH	1
Arnow, B; Blalock, JA; Blasey, C; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Riso, LP; Rothbaum, B; Rush, AJ; Thase, ME; Vivian, D	1
Argyropoulos, SV; Bell, CJ; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, SJ	1
Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J	1
Dunner, DL; Heim, CM; Keitner, G; Keller, MB; Klein, DN; Kornstein, S; McCullough, JP; Nemeroff, CB; Ninan, PT; Rothbaum, BO; Rush, AJ; Schatzberg, AF; Thase, ME; Weiss, PM	1
Arnow, B; Blalock, JA; Borian, FE; Castonguay, LG; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Miller, IW; Riso, LP; Rothbaum, B; Santiago, NJ; Schwartz, JE; Thase, ME; Vivian, D; Vocisano, C	1
Arnow, BA; Blalock, JA; Blasey, C; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Riso, LP; Rothbaum, BO; Rush, AJ; Thase, ME; Vivian, D	1
Calderone, A; Frasure-Smith, N; Lafontaine, S; Laliberté, MA; Lespérance, F; Rouleau, JL; Talajic, M; White, M	1
Ozpoyraz, N; Tamam, L	1
Fava, M; Kelly, K; Mischoulon, D; Opitz, G; Rosenbaum, JF	1
Feinn, R; Hernandez-Avila, CA; Kranzler, HR; Modesto-Lowe, V	1
Arnow, B; Borian, FE; Dunner, DL; Keitner, G; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; Rush, AJ; Trivedi, MH	1
Jahn, H; Kellner, M; Kiefer, F; Schick, M; Wiedemann, K; Yassouridis, A	1
Almási, J; Rihmer, Z	1
Arnow, BA; Banks, PL; Blalock, JA; Borian, FE; Howland, R; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Ninan, PT; Rothbaum, BO; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH	1
Cassidy, EL; Lauderdale, S; Sheikh, JI	1
Grannemann, BD; Mahadi, S; Morris, DW; Trivedi, MH	1
Clayton, AH; Montejo, AL	1
Arnow, BA; Blasey, C; Constantino, MJ; Klein, DN; Kocsis, JH; Manber, R; Markowitz, JC; Rush, AJ; Thase, ME	1
Goodwin, GM	1
Fava, M; Papakostas, GI	1
Blom, MB; Haffmans, PM; Hoencamp, E; Hoffman, T; Jonker, K; Spinhoven, P; van Dyck, R	1
Blom, MB; Dusseldorp, E; Haffmans, J; Hoencamp, E; Jonker, K; Spinhoven, P; van Dyck, R	1
Papakostas, GI; Shelton, RC	1
Belton, J; DeVega, E; DiGiovanni, S; Fuller, M; Liebling, D; Marqua, S; Sajatovic, M	1
Blume, AW; Cowley, DS; Jaffe, C; Kingsley, E; Pages, KP; Ries, RK; Roy-Byrne, PP; Russo, JE	1
D'Mello, DA; Meland, R; Ransom, S	1
Agelink, MW; Klieser, E; Linka, T; Majewski, T; Postert, T; Rotterdam, S; Wurthmann, C	1
Blanco, C; Davies, S; Goetz, D; Lewis-Fernández, R; Liebowitz, M; Salmán, E; Sánchez-Lacay, JA	1
Jerome, L	1
Baldwin, DS; Hawley, CJ; Mellors, K	1
Gillin, JC; Goyette, LM; Kelsoe, J; Marler, MR; Raimo, E; Rapaport, MH; Schnierow, B; Smith-Vaniz, A; Stein, MB; Zisook, S	1
Borian, FE; Crits-Christoph, P; Dunner, DL; Hirschfeld, RM; Keitner, G; Keller, MB; Klein, DN; Koran, LM; Kornstein, SG; Markowitz, JC; Miller, I; Nemeroff, CB; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH	1

Reviews

6 review(s) available for triazoles and Depression, Involutional

Article	Year
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2016
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry research, 2003, Sep-30, Volume: 120, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Male; Paroxetine; Piperazines; Polysomnography; Sleep; Sleep Stages; Triazoles	2003
[Review of antidepressants from the TCAs to the third generation drugs]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2004, Volume: 6, Issue:4 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride	2004
Major depressive disorder, antidepressants, and sexual dysfunction. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 6 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Piperazines; Sexual Dysfunctions, Psychological; Triazoles	2006
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:7 Topics: Depressive Disorder, Major; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Trazodone; Triazoles	2007
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Acta psychiatrica Scandinavica, 2008, Volume: 117, Issue:4 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles	2008

Trials

34 trial(s) available for triazoles and Depression, Involutional

Article	Year
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational psychiatry, 2019, 09-03, Volume: 9, Issue:1 Topics: Adult; Antidepressive Agents; Arousal; Depressive Disorder, Major; Diphenhydramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Pyrroles; Sleep; Treatment Outcome; Triazoles	2019
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial. Journal of psychopharmacology (Oxford, England), 2020, Volume: 34, Issue:9 Topics: Adolescent; Adult; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Double-Blind Method; Electroencephalography; Humans; Inflammation; Male; Purinergic P2X Receptor Antagonists; Pyridines; Translational Research, Biomedical; Triazoles; Young Adult	2020
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2021, Volume: 51 Topics: Cognition; Depressive Disorder, Major; Double-Blind Method; Humans; Nicotine; Pyridines; Receptors, Nicotinic; Treatment Outcome; Triazoles	2021
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study. The international journal of neuropsychopharmacology, 2021, 12-08, Volume: 24, Issue:12 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pyrimidines; Pyrroles; Treatment Outcome; Triazoles	2021
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia. Journal of psychopharmacology (Oxford, England), 2019, Volume: 33, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Cross-Over Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Orexin Receptor Antagonists; Polysomnography; Pyrimidines; Pyrroles; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Young Adult	2019
Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression. Journal of consulting and clinical psychology, 2013, Volume: 81, Issue:5 Topics: Adult; Antidepressive Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; Sensitivity and Specificity; Treatment Outcome; Triazoles	2013
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Participation; Personality Inventory; Piperazines; Triazoles	2009
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. Journal of affective disorders, 2009, Volume: 117, Issue:3 Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Culture; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Disorders; Personality Inventory; Piperazines; Problem Solving; Recurrence; Triazoles	2009
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Psychological medicine, 2010, Volume: 40, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Marriage; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Remission Induction; Self Disclosure; Treatment Outcome; Triazoles; Young Adult	2010
Differential effects of treatments for chronic depression: a latent growth model reanalysis. Journal of consulting and clinical psychology, 2010, Volume: 78, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Models, Psychological; Personality Inventory; Piperazines; Psychometrics; Secondary Prevention; Triazoles	2010
Treatment of depression in patients from ethnic minority groups in the Netherlands. Transcultural psychiatry, 2010, Volume: 47, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cross-Cultural Comparison; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morocco; Netherlands; Piperazines; Psychotherapy; Suriname; Triazoles; Turkey	2010
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Sleep, 2003, Mar-15, Volume: 26, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Severity of Illness Index; Sleep Wake Disorders; Triazoles	2003
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. Psychological medicine, 2003, Volume: 33, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Interpersonal Relations; Learning; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles	2003
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry research, 2003, Sep-30, Volume: 120, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Male; Paroxetine; Piperazines; Polysomnography; Sleep; Sleep Stages; Triazoles	2003
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biological psychiatry, 2003, Oct-15, Volume: 54, Issue:8 Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Eligibility Determination; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Recurrence; Substance Withdrawal Syndrome; Triazoles	2003
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proceedings of the National Academy of Sciences of the United States of America, 2003, Nov-25, Volume: 100, Issue:24 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Child; Child Abuse; Chronic Disease; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Triazoles	2003
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. Journal of consulting and clinical psychology, 2003, Volume: 71, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Piperazines; Professional-Patient Relations; Recurrence; Triazoles	2003
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. Journal of consulting and clinical psychology, 2003, Volume: 71, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Defense Mechanisms; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Personality Inventory; Piperazines; Psychometrics; Treatment Outcome; Triazoles	2003
An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:10 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Electrocardiography, Ambulatory; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Piperazines; Severity of Illness Index; Surveys and Questionnaires; Triazoles	2003
Nefazodone treatment of comorbid alcohol dependence and major depression. Alcoholism, clinical and experimental research, 2004, Volume: 28, Issue:3 Topics: Adult; Alcoholism; Analysis of Variance; Chi-Square Distribution; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Triazoles	2004
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacology bulletin, 2003, Volume: 37, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Observer Variation; Piperazines; Triazoles	2003
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Archives of general psychiatry, 2004, Volume: 61, Issue:12 Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents; Cortodoxone; Dehydroepiandrosterone; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluvoxamine; Humans; Male; Metyrapone; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles	2004
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Archives of general psychiatry, 2005, Volume: 62, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Cross-Over Studies; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Regression Analysis; Survival Analysis; Treatment Outcome; Triazoles	2005
Mixed anxiety and depression in older adults: clinical characteristics and management. Journal of geriatric psychiatry and neurology, 2005, Volume: 18, Issue:2 Topics: Aged; Aging; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles	2005
Symptom clusters as predictors of late response to antidepressant treatment. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Piperazines; Principal Component Analysis; Prognosis; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles	2005
Dropouts versus completers among chronically depressed outpatients. Journal of affective disorders, 2007, Volume: 97, Issue:1-3 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Dropouts; Physician-Patient Relations; Piperazines; Risk Factors; Triazoles	2007
Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. Journal of affective disorders, 2007, Volume: 104, Issue:1-3 Topics: Adolescent; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Interpersonal Relations; Male; Personality Disorders; Piperazines; Psychotherapy; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles	2007
Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychotherapy and psychosomatics, 2007, Volume: 76, Issue:5 Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Interpersonal Relations; Male; Piperazines; Psychotherapy; Triazoles	2007
Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity. Clinical therapeutics, 1999, Volume: 21, Issue:4 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Treatment Failure; Triazoles	1999
Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy, Group; Treatment Outcome; Triazoles	2000
Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues. Depression and anxiety, 2001, Volume: 13, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Hispanic or Latino; Humans; Male; Middle Aged; Patient Compliance; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles	2001
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment. Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:3 Topics: Adult; Aged; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome; Triazoles	2001
An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:10 Topics: Arousal; Combat Disorders; Depressive Disorder, Major; Dreams; Electroencephalography; Humans; Male; Middle Aged; Piperazines; Polysomnography; Sleep Stages; Treatment Outcome; Triazoles; Veterans	2001
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological psychiatry, 2002, Jan-15, Volume: 51, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Social Adjustment; Treatment Outcome; Triazoles	2002

Other Studies

12 other study(ies) available for triazoles and Depression, Involutional

Article	Year
Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant. The international journal of neuropsychopharmacology, 2022, 01-12, Volume: 25, Issue:1 Topics: Adult; Depressive Disorder, Major; Humans; Orexin Receptor Antagonists; Pyrimidines; Pyrroles; Triazoles	2022
QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice. Molecular neurobiology, 2023, Volume: 60, Issue:3 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Memory Disorders; Mice; Mice, Transgenic; Neuroinflammatory Diseases; tau Proteins; Triazoles	2023
Adverse reaction with suvorexant for insomnia: acute worsening of depression with emergence of suicidal thoughts. BMJ case reports, 2017, Oct-23, Volume: 2017 Topics: Antidepressive Agents; Azepines; Depressive Disorder, Major; Diagnosis, Differential; Female; Humans; Hypnotics and Sedatives; Middle Aged; Orexin Receptor Antagonists; Sleep Initiation and Maintenance Disorders; Suicidal Ideation; Treatment Outcome; Triazoles	2017
How multiple medication use evolves and the importance of therapeutic trials: the slippery slide. Journal of psychiatric practice, 2008, Volume: 14, Issue:3 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Asthma; Bronchodilator Agents; Buspirone; Clozapine; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Humans; Long-Term Care; Patient Care Team; Piperazines; Referral and Consultation; Schizophrenia; Schizophrenic Psychology; Theophylline; Triazoles	2008
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. Journal of consulting and clinical psychology, 2008, Volume: 76, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; ROC Curve; Severity of Illness Index; Time Factors; Triazoles	2008
Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2002, Volume: 14, Issue:4 Topics: Adult; Anger; Antidepressive Agents, Second-Generation; Chronic Disease; Clinical Trials as Topic; Combat Disorders; Depressive Disorder, Major; Follow-Up Studies; Humans; Male; Middle Aged; Middle East; Patient Compliance; Piperazines; Sleep; Treatment Outcome; Triazoles; Veterans	2002
Discontinuation symptoms associated with nefazodone. Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles	2003
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment. Depression and anxiety, 2004, Volume: 19, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Piperazines; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; Triazoles	2004
Aromatase inhibitors and bipolar mood disorder: a case report. Bipolar disorders, 2006, Volume: 8, Issue:5 Pt 1 Topics: Aggression; Anastrozole; Aromatase Inhibitors; Bipolar Disorder; Breast Neoplasms; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Irritable Mood; Letrozole; Middle Aged; Nitriles; Substance Withdrawal Syndrome; Triazoles	2006
Nefazodone and hypotension: complication or coincidence. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cohort Studies; Depressive Disorder, Major; Female; Humans; Hypotension; Male; Middle Aged; Piperazines; Retrospective Studies; Triazoles	1997
Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. Journal of affective disorders, 2001, Volume: 62, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Case-Control Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Down-Regulation; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Serotonin; Sympathetic Nervous System; Triazoles	2001
Bupropion and drug-induced parkinsonism. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2001, Volume: 46, Issue:6 Topics: Bupropion; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Piperazines; Triazoles	2001